- iCAD (NASDAQ:ICAD) has signed a worldwide distribution agreement with Sectra, an international medical imaging IT and cybersecurity company.
- Through the agreement, ProFound AI and ProFound AI Risk will be offered through the Sectra Amplifier Marketplace, which will expand their access to more facilities and imaging centers worldwide, iCAD said.
- The FDA had cleared ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT), a high-performance, deep-learning, workflow solution trained to detect malignant soft tissue densities and calcifications, in March.